Series Overview

One hour didactic session where speakers deliver clinical, basic science and translational talks on neurology and neuroscience related topics.  Speakers include UW neurology department faculty members, including neuropsychologists, researchers, clinical faculty, neurology residents, as well as other UW clinicians/researchers or invited speakers from outside UW.

Target Audience

MD, medical students, PhD (faculty, post-docs) graduate students, Researchers and Scientists, MDPhDs, DO, NPs, PAs, RN, APRN, Psychologists, Faculty and resident specialties including neurology (adult and pediatric neurology, neuropsychology), neurosurgery, neuroradiology, interventional neuroradiology, developmental pediatrics

Planning Committee

Accreditation

Accreditation Statement

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statements

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Education Units

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.

POLICY ON FACULTY AND SPONSOR DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.

* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

Detailed disclosures will be available prior to the start of the activity.

Disclosures for Planning Committee
Disclosures for Planning Committee - March 1, 2022 to June 30, 2022